Literature DB >> 12324464

The Rho GTPase effector protein, mDia, inhibits the DNA binding ability of the transcription factor Pax6 and changes the pattern of neurite extension in cerebellar granule cells through its binding to Pax6.

Tomoko Tominaga1, Wenxiang Meng, Kazuya Togashi, Hiroko Urano, Arthur S Alberts, Makoto Tominaga.   

Abstract

mDia, one of the target proteins of the GTPase Rho, is known to be involved in cytoskeletal reorganization and cytokinesis. Here, we report that mDia enters the nucleus and binds to the transcription factor, Pax6. In cultured non-neuronal cells, overexpression of mDia with Pax6 causes redistribution of some Pax6 molecules from the nucleus to the cytosol and decreases Pax6 transcriptional activity. Because Pax6 functions in the early central nervous system morphogenesis, we also examined the effects of mDia on endogenous Pax6 localization and neurite extension in cerebellar granule cells. Here too, Pax6 was partially mislocalized to the cytosol, and its expression level was decreased by mDia overexpression. In addition, mDia overexpression in these cells led to increased neurite branching and length. These results strongly suggest that mDia influences Pax6-induced transcriptional activity and axonal pathfinding in a way opposite from ROCK (Rho kinase) and that it may act via Pax6 to modulate early neuronal development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12324464     DOI: 10.1074/jbc.M207539200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Interaction of Pax6 with SPARC and p53 in brain of mice indicates Smad3 dependent auto-regulation.

Authors:  Ratnakar Tripathi; Rajnikant Mishra
Journal:  J Mol Neurosci       Date:  2010-02-23       Impact factor: 3.444

2.  WW domains provide a platform for the assembly of multiprotein networks.

Authors:  Robert J Ingham; Karen Colwill; Caley Howard; Sabine Dettwiler; Caesar S H Lim; Joanna Yu; Kadija Hersi; Judith Raaijmakers; Gerald Gish; Geraldine Mbamalu; Lorne Taylor; Benny Yeung; Galina Vassilovski; Manish Amin; Fu Chen; Liudmila Matskova; Gösta Winberg; Ingemar Ernberg; Rune Linding; Paul O'donnell; Andrei Starostine; Walter Keller; Pavel Metalnikov; Chris Stark; Tony Pawson
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

Review 3.  Formins and microtubules.

Authors:  F Bartolini; G G Gundersen
Journal:  Biochim Biophys Acta       Date:  2009-07-23

4.  The actin-cytoskeleton pathway and its potential role in inflammatory bowel disease-associated human colorectal cancer.

Authors:  Ziad Kanaan; Motaz Qadan; Maurice Robert Eichenberger; Susan Galandiuk
Journal:  Genet Test Mol Biomarkers       Date:  2010-06

5.  A screen for proteins that interact with PAX6: C-terminal mutations disrupt interaction with HOMER3, DNCL1 and TRIM11.

Authors:  Simon T Cooper; Isabel M Hanson
Journal:  BMC Genet       Date:  2005-08-12       Impact factor: 2.797

6.  Essential and nonredundant roles for Diaphanous formins in cortical microtubule capture and directed cell migration.

Authors:  Pascale Daou; Salma Hasan; Dennis Breitsprecher; Emilie Baudelet; Luc Camoin; Stéphane Audebert; Bruce L Goode; Ali Badache
Journal:  Mol Biol Cell       Date:  2014-01-08       Impact factor: 4.138

7.  Regulation of cerebral cortical neurogenesis by the Pax6 transcription factor.

Authors:  Martine N Manuel; Da Mi; John O Mason; David J Price
Journal:  Front Cell Neurosci       Date:  2015-03-10       Impact factor: 5.505

8.  Diaphanous-related formin mDia2 regulates beta2 integrins to control hematopoietic stem and progenitor cell engraftment.

Authors:  Yang Mei; Xu Han; Yijie Liu; Jing Yang; Ronen Sumagin; Peng Ji
Journal:  Nat Commun       Date:  2020-06-23       Impact factor: 14.919

9.  mDia1-3 in mammalian filopodia.

Authors:  Wah Ing Goh; Sohail Ahmed
Journal:  Commun Integr Biol       Date:  2012-07-01

10.  Differential Toxicity of mDia Formin-Directed Functional Agonists and Antagonists in Developing Zebrafish.

Authors:  Hunter LeCorgne; Andrew M Tudosie; Kari Lavik; Robin Su; Kathryn N Becker; Sara Moore; Yashna Walia; Alexander Wisner; Daniel Koehler; Arthur S Alberts; Frederick E Williams; Kathryn M Eisenmann
Journal:  Front Pharmacol       Date:  2018-04-10       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.